Which Is the Better Small-Cap ETF: Vanguard's VBK or Invesco's RZG?

VBK and RZG both target U.S. small-cap growth stocks, but VBK is materially cheaper at a 0.05% expense ratio versus RZG’s 0.35% and much larger at $38.7B in AUM versus $119.1M. Performance was nearly identical over 1 year, with returns of 43.4% for VBK and 43.1% for RZG, while five-year max drawdowns were also similar at -38.39% and -38.31%. VBK offers broader diversification with 579 holdings versus RZG’s 130, while RZG has greater concentration and higher liquidity/friction risk.

Analysis

The market takeaway is not that one fund is “better,” but that the small-cap growth factor itself is behaving like a blunt instrument: a 579-name basket and a 130-name basket are producing nearly the same one-year result, which tells me dispersion inside the sleeve is still low enough that index construction is doing more work than stock selection. In that regime, the cheaper, broader vehicle tends to win because any idiosyncratic alpha from concentration is too diluted to overcome the fee drag.

The bigger second-order implication is for the underlying names with the highest index sensitivity. RZG’s heavier dependence on a narrower set of healthcare and industrial growth names makes it more vulnerable to a rebalance shock if factor leadership rotates away from “pure growth” and toward profitability or quality; that would hit names like POWL/AGX/ACMR faster than the broader benchmark because annual reconstitution can force mechanical selling into weak tape. By contrast, VBK’s depth reduces single-name risk but also means it is slower to express any sharp rebound in a few high-beta winners.

Liquidity is the hidden catalyst. With RZG’s tiny asset base, spread and creation/redemption friction can matter more than headline expense ratio, especially if small-cap flows reverse and authorized participants widen pricing bands; that risk is months, not days, but it becomes acute in a drawdown. For holders of the underlying stocks, the cleanest read-through is that inclusion in a concentrated “pure growth” index can create temporary flow support, but it is not durable demand and can vanish at the next annual rebalance.

The contrarian view is that investors may be over-optimizing for diversification when the real opportunity in small caps is concentration in the few businesses with visible earnings inflection. If growth leadership broadens and rates stabilize, a concentrated basket could outperform despite the fee penalty; if not, the cheaper wrapper should continue to compound the same exposure with less friction.

Key Decisions for Investors

• Prefer VBK over RZG for core small-cap growth exposure over the next 6-12 months; same factor exposure, materially lower fee drag, and better secondary liquidity profile.
• If expressing a tactical high-growth rebound, use RZG as a smaller satellite position only on weakness after annual rebalance windows; target a 1-2 quarter horizon with strict liquidity limits.
• Long CIEN / short RZG basket for 1-3 months if you expect growth leadership to broaden away from the most concentrated pure-growth names; CIEN has enough index relevance to outperform on relative flows while RZG absorbs the rebalance risk.
• For investors already long POWL, AGX, or ACMR, trim into strength rather than add after index-driven support; the incremental buyer is likely mechanical, so upside can fade quickly once reconstitution demand clears.
• Use VBK call spreads instead of stock if seeking a medium-term small-cap growth beta expression; the lower fee wrapper plus broad diversification gives cleaner upside participation with less single-name event risk.